Episode description
Episode description
Shares of Walmart jumping on the back of a strong earnings report. What the retailer is saying about the state of the consumer, and why they see sales improving. Plus The Biden Administration unveiling drug prices subject to Medicare negotiations. The names being impacted, and how the pharma space will fare.